1. Home
  2. PCOR vs PRAX Comparison

PCOR vs PRAX Comparison

Compare PCOR & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PCOR

Procore Technologies Inc.

HOLD

Current Price

$49.80

Market Cap

8.4B

Sector

Technology

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$342.82

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCOR
PRAX
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
9.0B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PCOR
PRAX
Price
$49.80
$342.82
Analyst Decision
Buy
Strong Buy
Analyst Count
16
15
Target Price
$74.19
$572.13
AVG Volume (30 Days)
2.7M
324.8K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
6.94
N/A
EPS
N/A
N/A
Revenue
$1,322,509,000.00
N/A
Revenue This Year
$15.24
N/A
Revenue Next Year
$12.99
$7,758.26
P/E Ratio
N/A
N/A
Revenue Growth
14.83
N/A
52 Week Low
$45.02
$37.25
52 Week High
$82.32
$366.52

Technical Indicators

Market Signals
Indicator
PCOR
PRAX
Relative Strength Index (RSI) 48.45 53.49
Support Level $46.48 $282.49
Resistance Level $59.42 $353.86
Average True Range (ATR) 2.28 18.79
MACD 0.16 0.89
Stochastic Oscillator 57.05 62.82

Price Performance

Historical Comparison
PCOR
PRAX

About PCOR Procore Technologies Inc.

Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: